November 3–5, 2025
Vienna Congress and Convention Center, Vienna, AustriaNovember 11–12, 2025 | Digital Partnering Bernd BoidolCEO at ProxygenSpeaker
Profile
Dr. Bernd Boidol is CEO of Proxygen, a biotech leader in molecular glue degraders targeting previously undruggable proteins. With a PhD in Oncology and degrees in Molecular Biology and Business Administration, he blends scientific and commercial expertise. Since 2020, he has propelled Proxygen into strategic partnerships with the industry's biggest players, such as Merck & Co. and Merck KGaA, positioning the company at the forefront of next-generation therapeutics. Under his leadership, Proxygen has developed a proprietary discovery engine and advanced its internal pipeline toward clinical development, earning recognition as one of Fierce Biotech's "Fierce 15" companies in 2023 and beyond.